REMINDER: Our focusIR Investor Webinar takes place TONIGHT with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Share News (SHP)

  • There is currently no data for SHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: Stocks Higher As Shire And Whitbread Gain

Fri, 14th Sep 2018 12:01

LONDON (Alliance News) - Stocks in London were higher at midday on Friday with Shire and Whitbread performing well among FTSE 100 constituents, while in the FTSE 250, Investec was benefiting from its plan to demerge its asset management businesses. The FTSE 100 index was 0.4%, or 27.10 points, at 7,308.72 at midday. The FTSE 250 was up 0.5%, or 97.90 points to 20,341.44, while the AIM All-Share index was flat at 1,097.10.The Cboe UK 100 index was up 0.3%, or 40.75 points, at 12,372.97. The Cboe UK 250 was up 0.5%, or 94.09 points to 18,487.59, and the Cboe UK Small Companies was down 0.1% at 12,190.36."European stocks are slightly higher this morning as traders are cautiously optimistic about the state of global trade. The US and China are still locked in a trade spat, and both sides are content to hold their positions. Traders are viewing no new negative news as a positive for stocks," said CMC Markets analyst David Madden. On the London Stock Exchange, Shire was the best performer in the FTSE 100, up 2.4% at 4,502.50 pence after Takeda Pharmaceutical said it had received regulatory clearance in China for its GBP46 billion acquisition of the Irish drugmaker. The Japanese firm received unconditional approval for the deal announced in May from the State Administration for Market Regulation in China in what it termed "another key step" in the transaction process. Chinese approval follows progress with other global regulators. In July, the deal received the green light from the US Federal Trade Commission. It also has received unconditional approval from the Brazilian Administrative Council for Economic Defense. Under the deal, Takeda will pay USD30.33 in cash and 0.839 of a new Takeda share for each Shire share. This values the deal at around 4,990 pence per Shire share based on current prices and exchange rates.Another blue-chip winner was Whitbread, which was up 1.5%. The Costa Coffee shop and Premier Inn hotel chain owner was raised to Overweight from Neutral. Last month, Whitbread agreed to sell Costa to Coca-Cola for GBP3.8 billion and return the vast majority of that to shareholders.In the FTSE 250, Investec was the best performer, up 8.4%. The Anglo-South African financial services firm said its interim profit is expected to be ahead of last year, as it also announced plans to demerge and publicly list its Asset Management unit. Following the conclusion of a strategic review, the company said that there are "compelling" linkages between its Specialist Banking and Wealth & Investment business. However, there are "limited synergies" between both of these divisions and Investec Asset Management. Therefore, the board has decided to demerge and publicly list the asset management unit. Separately, Investec said although its first half saw "macro challenges" in both South Africa and the UK, operating profit for the period is expected to be above last year.At the other end of the FTSE 250, JD Wetherspoon was down 0.9%. The pub chain said taxes, labour, and interest costs are expected to be higher year-on-year, despite reporting growth in profit. For the 52 weeks to July 29, Wetherspoons recorded pretax profit of GBP107.2 million, up 4.3% year-on-year, with pretax profit rising 6.2% excluding an extra week in its prior financial year.Revenue was GBP1.69 billion compared to GBP1.66 billion a year before. Like-for-like sales, adjusted for 52 weeks, increased by 5.0% versus 4.0% the year prior. Looking ahead, the company estimates it will be required to achieve like-for-like sales growth of about 4.0% in its new financial year to match Friday's profit figure. Same store sales in the six weeks to September 9 were up 5.5%, a "reasonable" start to the year.Wetherspoon's opened six pubs during its year, with 18 sold or closed, resulting in a trading estate of 883 pubs at end of its 2018 financial year.The pound was quoted at USD1.3125 compared to USD1.3101 at the London equities close on Thursday. Bank of England Governor Mark Carney warned UK ministers that house prices could crash by more than a third in the event of a chaotic no-deal Brexit. Carney briefed Prime Minister Theresa May and senior ministers on the bank's planning for a "cliff-edge" break with the EU at a special Cabinet meeting on Thursday to review the government's no-deal preparations. It is understood he warned house prices could fall by up to 35% over three years in a worst-case scenario, as sterling plummeted and the Bank was forced to push up interest rates. According to reports, he compared the fall-out from such a disorderly departure to the 2008 global financial crash. Ministers were said to have listened in silence as he and Chancellor Philip Hammond spelled out the grim consequences for the economy. His bleak prognosis came as France said it could halt flights and Eurostar trains from the UK if there was no agreement when the UK leaves the EU in March 2019."Mark Carney is risking the ire of hard Brexiteers once more this morning as the governor for the Bank of England has warned that a no-deal Brexit could lead to economic chaos which would see house price crash by as much as a third," said XTB analyst David Cheetham. "On the flip side, Carney also noted that PM May's much maligned Chequers exit plan, should it manage to be agreed upon, would see the economy perform better than the bank's assumed outcome," Cheetham added. On Thursday, Bank of England policymakers unanimously decided to maintain their monetary policy stance unchanged after a quarter-point rate hike in August. The Monetary Policy Committee voted 9-0 to keep the key rate unchanged at 0.75%.In Paris the CAC 40 was up 0.4%, while the DAX 30 in Frankfurt was up 0.3%. The euro was quoted at USD1.1697 at midday, marginally higher against USD1.1673 European equities close Thursday. US stocks are pointed towards a slightly higher start on Friday. The Dow Jones called up 0.1%, S&P 500 flat and Nasdaq Composite up 0.2%."The US economy has been gathering positive momentum despite the risk of a trade war and today's retail sales data is expected to provide further evidence of that, with spending expected to have risen by 0.4% last month. This would continue the steady trend of rising sales over the course of the year as consumers spend the additional income that tax cuts afforded them thanks to last year's reforms," said Oanda analyst Craig Erlam.Still to come in the economics events calendar are US retail sales and import and export prices at 1330 BST.
More News
6 Sep 2019 07:54

UPDATE 1-Sumitomo Dainippon Pharma investing $3 bln in Swiss Roivant in overseas push

* Dainippon to buy 10% stake in Roivant and interests in 5 units * Schizophrenia treatment Latuda to lose US exclusivity in 2023 * Japan pharma firms grapple with declining Dainippon

Read more
14 Aug 2019 06:45

UPDATE 1-Germany's Stada 'very selective' on acquisitions - CEO Goldschmidt

FRANKFURT, Aug 14 (Reuters) - German generic drugmaker Stada will be careful about buying businesses and companies outright, and for now will focus mainly on striking production and development we

Read more
17 Jul 2019 17:55

Takeda kicks off sale of Western European drugs - sources

By Arno Schuetze and Pamela Barbaglia FRANKFURT/LONDON, July 17 (Reuters) - Japan's Takeda Pharmaceutical Co has reached out to prospective bidders for a portfolio of drugs for sale in

Read more
16 May 2019 18:35

Japan's Takeda expects binding offers for Latam business by end of May -sources

By Tatiana Bautzer SAO PAULO, May 16 (Reuters) - Japan's Takeda Pharmaceutical Co expects to receive binding offers for its Latin American business by the end of May, three sources of a

Read more
15 May 2019 08:05

Nikkei snaps 7-day losing streak helped by China's stimulus hopes

* Gains may be short-lived - analyst * Takeda Pharma, Nissan sink after earnings shock * Mitsubishi Estate jumps on share buyback, governance reform By Hideyuki Sano and Ayai

Read more
15 May 2019 04:04

Nikkei hobbled by trade worries, disappointing earnings

* Nikkei down slightly after 7 losing sessions * Uncertainties over U.S.-China standoff keep investors on edge * Takeda Pharma, Nissan sink after earnings shock * Mitsubishi -

Read more
14 May 2019 07:56

UPDATE 1-Japan's Takeda forecasts 193 bln yen annual operating loss on Shire deal

* 193 bln Y op loss forecast this yr vs 227.5 bln profit view of analysts * Shire acquisition made Takeda one of the world's most indebted drugmakers (Adds details of results, May 14 -

Read more
14 May 2019 07:39

Japan's Takeda expects annual loss on Shire deal

TOKYO, May 14 (Reuters) - Takeda Pharmaceutical Co forecast on Tuesday it would have an operating loss in the current financial year, as it books costs associated with the multibillion-dollar an a

Read more
9 May 2019 00:38

UPDATE 1-Novartis buys Takeda's dry eye drug for $3.4 bln

May 8 (Reuters) - Swiss drugmaker Novartis AG said on Wednesday it agreed to acquire Takeda Pharmaceutical Company Ltd's dry eye drug Xiidra for $3.4 billion, as well as potential milestone of

Read more
1 Feb 2019 06:07

Japan's Takeda posts 28 pct rise in Q3 operating profit

TOKYO, Feb 1 (Reuters) - Takeda Pharmaceutical Co Ltd on Friday posted a 27.9 percent rise in third-quarter operating profit, supported by strong sales of its drugs for bowel disease and multiple

Read more
22 Jan 2019 02:46

Nikkei dips as global growth concerns sap risk appetite

* IMF cuts global growth forecasts * Companies with big China exposure fall * Totech soars after raising earnings forecast By Ayai Tomisawa TOKYO, Jan 22 (Reuters) - in

Read more
8 Jan 2019 13:54

MARKET ANALYSIS: Optimism About Trade Talks May Generate Continued Buying Interest

WASHINGTON (Alliance News) - The major US index futures are pointing to a higher opening on Tuesday, with stocks likely to extend the strong upward move seen over the two previous about trade the

Read more
8 Jan 2019 08:58

Asian Shares Mixed Despite US-China Trade Deal Optimism

CANBERA (Alliance News) - Asian stocks ended mixed on Tuesday despite optimism over US-China trade talks as US officials held a second day of trade talks with Chinese counterparts in second day of

Read more
8 Jan 2019 07:39

Takeda takes control of Shire

(Sharecast News) - Takeda Pharmaceutical has taken full control of Shire after the legal particulars of its cash and share offer were completed.

Read more
7 Jan 2019 04:29

Takeda unlikely to sell OTC drug business -CEO

(Adds quote, other details) TOKYO, Jan 7 (Reuters) - Takeda Pharmaceutical is unlikely to sell its over-the-counter (OTC) drug business even amid pressure to improve its finances as it a a

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.